GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » Total Payout Ratio

Sinclair Pharma (XPAR:SPH) Total Payout Ratio : 0.00 (As of Jun. 20, 2024)


View and export this data going back to . Start your Free Trial

What is Sinclair Pharma Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Sinclair Pharma's current Total Payout Ratio is 0.00.


Sinclair Pharma Total Payout Ratio Historical Data

The historical data trend for Sinclair Pharma's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinclair Pharma Total Payout Ratio Chart

Sinclair Pharma Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Dec17
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.52 4.50 - -

Sinclair Pharma Semi-Annual Data
Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Jun17 Dec17 Jun18
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sinclair Pharma's Total Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sinclair Pharma's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinclair Pharma's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sinclair Pharma's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Sinclair Pharma's Total Payout Ratio falls into.



Sinclair Pharma Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Sinclair Pharma's Total Payout Ratio for the fiscal year that ended in Dec. 2017 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -4.919
=0.00

Sinclair Pharma's Total Payout Ratio for the quarter that ended in Jun. 2018 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -12.925
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinclair Pharma Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinclair Pharma (XPAR:SPH) Business Description

Traded in Other Exchanges
N/A
Address
Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.